title: Adalimumab (Humira®) for Hidradenitis Suppurativa.
authors: Department of Medicine, University of Toronto School of Medicine, Department of Medicine, Toronto, Ontario, Canada; agupta@execulink.com.|Mediprobe Research Inc., London, Ontario, Canada.
authors: Aditya K
authors: AK
authors: Gupta
authors: Mediprobe Research Inc., London, Ontario, Canada.
authors: Maria
authors: M
authors: Cernea
authors: Department of Medicine, Baylor University Medical Center, Dallas, TX.|Departments of Dermatology and Family Practice, University of Texas Southwestern Medical School, Dallas, TX.|Dermatology Treatment and Research Center, Dallas, TX.
authors: William
authors: W
authors: Abramovits
authors: Belle Meade Dermatology, Nashville, TN.
authors: Kimberly Dawn
authors: KD
authors: Vincent
mesh_terms: D000068879:Adalimumab / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D017497:Hidradenitis Suppurativa / Q000188:drug therapy*; D006801:Humans
chemical_list: D000893:Anti-Inflammatory Agents; D000068879:Adalimumab